4th European Biosimilars Conference

Published: 27-Sep-2016

Biosimilar medicines' developments are maintaining their momentum and the 2016 Biosimilars Conference programme will cover three main topics: Pharmacovigilance and clinical practice; Market and regulatory developments in the EU and globally; and the impact of biosimilar medicines on the competitive landscape of biological products, in light of 10 years of market existence.

Organiser: DIA Drug Information Association

You may also like